Seven-year follow-up of the immune response after one or 2 doses of inactivated hepatitis A vaccine given at 1 year of age in the Mendoza Province of Argentina
Authors:
Open Access
- 25 July 2017
- journal article
- research article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 13 (11) , 2707-2712
Abstract
This monocenter, descriptive, prospective, non-interventional study evaluated the long-term immune responses following routine vaccination with one or 2 doses of a licensed inactivated hepatitis A (HA) vaccine (Avaxim® 80U Pediatric) at age 11–23 months in a cohort of children from Mendoza, Argentina. Antibodies to hepatitis A virus (anti-HAV) were quantified annually up to Y5, and at Y7. Children whose titer decreased to below the seroprotection threshold (defined as an anti-HAV antibody concentration of ≥ 10 mIU/mL in a microparticle enzyme immunoassay up to Y5, or ≥ 3 mIU/mL in an electrochemiluminescence immunoassay at Y7) received a routine booster dose of the same HA vaccine. This report summarizes the data at 7 year after the first vaccination. Of 546 participants initially included, 264 participants remained at Y7 and provided blood samples. Of these, 204 having received one HA primary dose as a toddler were still seroprotected at Y7; titers for a further 7 also having received one HA dose as a toddler fell to below the seroprotection threshold and they therefore received a booster; all 53 having received 2 HA doses as a toddler and still present at Y7 remained seroprotected at Y7. One or 2 primary doses of this HA vaccine in toddlers result in very good persistence of anti-HAV up to 7 year post-first vaccination.Keywords
This publication has 20 references indexed in Scilit:
- Single-Dose Universal Hepatitis A Immunization in Argentina: Low Viral Circulation and High Persistence of Protective Antibodies Up to 4 YearsJournal of the Pediatric Infectious Diseases Society, 2014
- Impact of the Single-dose Immunization Strategy Against Hepatitis A in ArgentinaThe Pediatric Infectious Disease Journal, 2014
- Acute Liver FailureNew England Journal of Medicine, 2013
- Persistence of immunity from 1 year of age after one or two doses of hepatitis A vaccine given to children in ArgentinaHepatic Medicine: Evidence and Research, 2012
- The cost-effectiveness of universal vaccination of children against hepatitis A in Argentina: results of a dynamic health–economic analysisJournal of Gastroenterology, 2007
- O0062 ACUTE LIVER FAILURE IN CHILDREN: EXPERIENCE WITH 210 PATIENTSJournal of Pediatric Gastroenterology and Nutrition, 2004
- Hepatitis A booster vaccination: is there a need?The Lancet, 2003
- Sensitive assays for hepatitis a antibodiesJournal of Medical Virology, 1993
- Time course of hepatitis A antibody production after active, passive and active/passive immunisation: The results are highly dependent on the antibody test system usedJournal of Virological Methods, 1993
- Serum Neutralizing Antibody Response to Hepatitis A VirusThe Journal of Infectious Diseases, 1983